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REGULAR ARTICLE
SNARE-dependent membrane fusion initiates a-granule matrix
decondensation in mouse platelets
Irina D. Pokrovskaya,1,* Smita Joshi,2,* Michael Tobin,3 Rohan Desai,3 Maria A. Aronova,3 Jeffrey A. Kamykowski,1 Guofeng Zhang,3
Sidney W. Whiteheart,2 Richard D. Leapman,3 and Brian Storrie1
1Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR; 2Department of Molecular and Cellular Biochemistry, University of
Kentucky, Lexington, KY; and 3Laboratory of Cellular Imaging and Macromolecular Biophysics, National Institute of Biomedical Imaging and Bioengineering, National Institutes
of Health, Bethesda, MD
Key Points
• a-Granule matrix
decondensation, a
progressive fusion-
protein-dependent
process, potentiates
a-granule protein cargo
release.
• Release of a-granule
cargo, by primary or
sequential compound
fusion, occurs
predominantly through
PM-anchored fusion
pores.
Platelet a-granule cargo release is fundamental to both hemostasis and thrombosis. Granule
matrix hydration is a key regulated step in this process, yet its mechanism is poorly
understood. In endothelial cells, there is evidence for 2modes of cargo release: a jack-in-the-box
mechanism of hydration-dependent protein phase transitions and an actin-driven granule
constriction/extrusion mechanism. The third alternative considered is a prefusion,
channel-mediated granule swelling, analogous to the membrane “ballooning” seen in
procoagulant platelets. Using thrombin-stimulated platelets from a set of secretion-deficient,
soluble N-ethylmaleimide factor attachment protein receptor (SNARE) mutant mice and
various ultrastructural approaches, we tested predictions of these mechanisms to distinguish
which best explains the a-granule release process.We found that the granule decondensation/
hydration required for cargo expulsion was (1) blocked in fusion-protein-deficient platelets;
(2) characterized by a fusion-dependent transition in granule size in contrast to a preswollen
intermediate; (3) determined spatially with a-granules located close to the plasma
membrane (PM) decondensing more readily; (4) propagated from the site of granule fusion;
and (5) traced, in 3-dimensional space, to individual granule fusion events at the PM or less
commonly at the canalicular system. In sum, the properties of a-granule decondensation/
matrix hydration strongly indicate that a-granule cargo expulsion is likely by a
jack-in-the-box mechanism rather than by gradual channel-regulated water influx or by a
granule-constriction mechanism. These experiments, in providing a structural and mecha-
nistic basis for cargo expulsion, should be informative in understanding the a-granule release
reaction in the context of hemostasis and thrombosis.
Introduction
Upon detecting vascular lesions, platelets become activated and release components from at least 3
distinct storage compartments: a-granules, dense granules, and lysosomes (see reviews1-3). Granule
release is a key process in hemostasis as the secreted components are important for hemostatic plug
formation. Dense granules store and release small molecules such as adenosine diphosphate to provide
a paracrine function for inducing further platelet activation.4,5 In contrast, a-granules serve as the major
store for 100 to 200 different bioactive proteins that are released through exocytosis. Some are
adhesion factors for hemostatic plug formation, and others act as cytokines or growth factors that affect
cells adjacent to the damaged site (see reviews2,3). The a-granules are larger (.250 nm in width) and
more abundant than dense granules.1,6 The concentration of proteins within the a-granule is high, and,
Submitted 27 March 2018; accepted 3 October 2018. DOI 10.1182/
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by electron microscopy, the interior matrix is electron-dense rela-
tive to the cytosol.6 This appearance resembles the condensed,
dehydrated matrix observed in other protein storage granules, such
as the insulin-rich storage granules of the pancreatic islet cells,7
the digestive proenzyme-rich storage granules of pancreatic acinar
cells,8 or the von Willebrand factor (VWF)–rich Weibel-Palade
bodies (WPBs) of vascular endothelial cell.9 Within this a-granule
matrix, proteins are zonally distributed with some proteins (eg, VWF),
forming selectively self-associating oligomers,10,11 whereas others
(eg, fibrinogen) are more generally distributed.12-14 Overall, these
data suggest that the a-granule interior is structured as a con-
densed, poorly hydrated protein matrix, which must be dissolved
(ie, decondensed) during the platelet release reaction.
Matrix decondensation provides an attractive process to explain
significant aspects of the kinetic diversity that has been reported
for a-granule cargo release.15-18 In in vitro experiments, a-granule
fusion to the plasma membrane (PM; human or mouse platelets6,19),
or in some cases to the canalicular system (CS; mouse platelets19),
is via a short neck or a longer pipe that could restrict cargo efflux.6
Hence, platelet a-granule cargo is not expected to be released as a
bolus, unlike the cargo of small synaptic vesicles that fuse with
presynaptic membranes.20-22 Rather, it is proposed that the neck or
pipe functions as a restrictor valve that may modify cargo release on
the basis of either exit proximity, protein rehydration/solubilization
rates, or both. Morphologically, this model is supported by recent
evidence that the matrix decondensation process is completed only as
the proteins emerge extracellularly from a neck/pipe.6 These properties
of the a-granule release reaction and matrix decondensation provide a
viable explanation for the comparatively slow release kinetics of
a-granule proteins vs the fast release of small molecules, such as
serotonin, from dense granules,23 thus providing a structural basis for
kinetically ordered content release.18
The mechanisms for a-granule cargo expulsion remain poorly under-
stood. For the WPBs, there is evidence for at least 2 mechanisms of
cargo expulsion, depending on stimulus: a jack-in-the-box mechanism
of hydration-dependent, protein phase transitions occurring during
secretagogue-stimulated secretion,24,25 and an actin-driven granule
constriction mechanism occurring during phorbol ester–stimulated
secretion.26,27 A possible third mechanism is suggested by the
aquaporin-1-channel–mediated membrane water influx that drives
ballooning seen in procoagulant platelet formation.28 In this mecha-
nism, granules might preswell, prior to fusion, because of water influx
from the cytosol. Although actin’s role in WPB release has been well
documented,9 its role in platelets has been controversial.29-32 We
chose to directly test whether a-granule matrix expulsion meets the
predictions of a jack-in-the-box mechanism or the proposed alternatives.
We used soluble N-ethylmaleimide factor attachment protein receptor
(SNARE)–deficient transgenic mice and various ultrastructural
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Figure 1. a-Granule decondensation is a kinetic precursor
of granule exocytosis. Mouse platelets were stimulated, or
not, with thrombin for the indicated times, and reactions were
stopped by the addition of glutaraldehyde/paraformaldehyde
fixative. Aldehyde fixation can stop secretion in ,1 second
(cultured hippocampal neurons).38 (A) In electron micrographs of
thin sections from unstimulated mouse platelets (0 seconds),
a-granules appeared as round to ovoid structures marked by an
electron-dense matrix. Upon thrombin stimulation (B-C;
0.1 U/mL), there was distinct accumulation of expanded (ie,
decondensed) a-granules marked by residual loose fibrous matrix
components. The arrow in panel A points to a condensed
a-granule. The arrowheads in panels B-C point to examples of
compound-fused, decondensed a-granules. The white star in
panel B marks a decondensed a-granule showing variations in
apparent matrix density. (D) Quantification of condensed and
decondensed granules in platelets stimulated for increasing
times. Numbers of platelet profiles scored: 0 seconds/0 time,
n 5 50; 10 seconds, n 5 50; 20 seconds, n 5 47; 30 seconds,
n 5 45; 60 seconds, n 5 19; 90 seconds, n 5 145; 120
seconds, n 5 45; 300 seconds, n 5 41. Means and standard
errors of the mean are presented, and the graphs are color
coded: condensed (red) and decondensed (blue). P values
relative to 0 seconds were determined at 90 and 300 seconds.
Values for both condensed and decondensed granules were
statistically significant for both sets of comparisons. Asterisks
indicating statistical significance, as determined with Student
t test are as follows: **P # .01.
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Figure 2.
13 NOVEMBER 2018 x VOLUME 2, NUMBER 21 FUSION-DEPENDENT GRANULE MATRIX DECONDENSATION 2949
.For personal use onlyon April 9, 2019. by guest  www.bloodadvances.orgFrom 
approaches to test 5 central predictions of a jack-in-the-box
mechanism: (1) Any precursor-product relationship between
condensed and decondensed a-granules should be blocked in
granule fusion-defective platelets.33 (2) a-Granules, in stimulated
mouse platelets, should exhibit an abrupt, quantal transition in size as
granules decondense. (3) If granule fusion with the PM is the major
route of water influx, then peripherally located a-granules should
decondense first. (4) Granule fusion with the PM/CS or a
decondensed a-granule (ie, sequential compound fusion) should
lead to matrix hydration propagating from the site of membrane
fusion. (5) Decondensed granules should be traceable to PM/CS
fusion pores, be they single or compound fused granules. These
experimental predictions were validated by our data indicating
a-granule matrix expulsion in mouse platelets is most likely via a
jack-in-the-box mechanism, rather than by gradual channel-regulated
water influx and prefusion swelling or by granule constriction. These
experiments provide a mechanistic basis for the expulsion of
a-granule contents and should be informative to our understanding
of the a-granule release reaction in the context of hemostasis and
thrombosis.
Methods
See also supplemental Materials and methods.
Preparation of mouse platelets
Blood was collected by cardiac puncture and anticoagulated with
0.38% sodium citrate, 10 ng/mL prostaglandin I2, and 0.2 U/mL
apyrase. Blood from 3 to 5 mice of mixed genders was pooled for
each sample. Blood was diluted with N-2-hydroxyethylpiperazine-
N9-2-ethanesulfonic acid (HEPES) Tyrode buffer (pH 7.4, 20 mM
HEPES/KOH, 128 mM NaCl, 2.8 mM KCl, 1 mM MgCl2, 5 mM
D-glucose, 12 mM NaHCO3, 0.4 mM NaH2PO4) in 1:1 ratio in
presence of prostaglandin I2 and apyrase. Samples were then
centrifuged to yield a platelet-rich plasma. The platelet-rich plasma
was centrifuged, and the platelet pellets were resuspended in
HEPES Tyrode buffer (pH 7.4) with 1 mM EGTA and centrifuged
a final time to collect washed platelets. Platelet concentrations
were measured using a Z2 Counter (Beckman Coulter, Miami,
FL) and adjusted to 2.5 3 108/mL, and the platelet suspension
was supplemented with 0.7 mM CaCl2 before use. Mouse
platelet preparations were done at University of Kentucky by the
Sidney Whiteheart laboratory.
Platelet stimulation and electron microscopy studies
Washed platelets were activated, or not, with thrombin (0.1 U/mL)
for the indicated times, and the reactions were stopped with an
equal volume of 2% PFA and 5% glutaraldehyde (2X fixative). For
morphology studies of vesicle-associated membrane protein (VAMP)
knockout mutant platelets, platelets were stimulated with 0.1 U/mL
thrombin, and the reactions were stopped at either 90 or 300 seconds
with 2X fixative. Platelets were fixed at room temperature for 30minutes
and were recovered by centrifugation. The platelet pellets were
processed by high pressure freezing and freeze substitution de-
hydration (see supplemental Materials and methods).
Samples were analyzed by transmission electron microscopy, elec-
tron tomography (ET), serial block face scanning electron micros-
copy (SBF-SEM), or focused ion beam scanning electron microscopy
(FIB-SEM). Transmission electron microscopy and ET were performed
with an FEI TF20 microscope operated at a beam energy of 80 or 200
KeV, respectively. SBF-SEM was performed with a Gatan 3View
system mounted in a Zeiss Sigma SEM, FIB-SEM with a Zeiss
Crossbeam 550 SEM (see supplemental Materials and methods).
Platelets and their organelles were manually segmented and rendered
in 3 dimensions, and volumes were quantified using Amira software,
version 6.5.0 (Thermo Fisher FEI). For details, see supplemental
Materials and methods.
Statistical analysis
Statistical analysis was performed using the KaleidaGraph software
package for Mac (Synergy Software). Because the data sets were of
different sizes and from different individual samples, 2-tailed, unequal,
unpaired Student t tests were used to determine P values. The
normality of the data set distributions was validated by skewness/
kurtosis determinations.
Data sharing
Raw image stacks are available electronically to qualified
investigators.
Results
Biochemical and ultrastructural validation of the
SNARE-deficient mouse strains
The mouse strains, genetically altered for vesicle-SNAREs (v-SNARE)
expression were as previously characterized.33 Shown in supplemental
Figure 1, their platelets displayed the expected protein expression
levels and secretion defects. V2D3D platelets are devoid of VAMP2 and
3 while containing normal levels of the a-granule v-SNAREs VAMP8
and 7,23,34,35 as well as other exocytic machinery proteins. V82/2
platelets were devoid of VAMP8 and contained normal levels of the
other tested proteins, including VAMP7. Although platelets from
V2D3D82/2 mice were devoid of VAMP2, 3, and 8, they also had
reduced levels of VAMP7. V82/2 platelets exhibited partial inhibition of
thrombin-stimulated (0.1 U/mL) platelet factor 4 (PF4) secretion from
a-granules and b-hexosaminidase secretion from lysosomes with
limited effects on dense granules. A stronger effect on a-granule
secretion was achieved when the V82/2 was placed in a V2D3D
background. VAMP3 is an important endocytic SNARE36 and known
to have little effect on granule release.37 V2D3D platelets had no
Figure 2. Deletion of VAMP8 partially affected a-granule decondensation whereas deletion of VAMP8 in a V2D 3D background largely blocked a-granule
decondensation. Thin section electron microscopy of V2D3D (A), V82/2 (B), and V2D3D82/2 (C). Platelets stimulated with thrombin for 0, 90, and 300 seconds are shown.
(D) Number of platelet profiles scored: WT: (0 seconds/0 time, n 5 200), (90 seconds, n 5 145), (300 seconds, n 5 41); V82/2: (0 seconds, n 5 50), (90 seconds, n 5 50),
(300 seconds, n 5 50). (E) Number of platelet profiles scored: V2D3D: (0 seconds, n 5 100), (90 seconds, n 5 50), (300 seconds, n 5 50); V2D3D82/2: (0 seconds,
n 5 100), (90 seconds, n 5 50), (300 seconds, n 5 38). Means and standard errors of the mean are presented, and graphs are color coded as indicated. P values were
calculated, using Student t test, and asterisks indicating statistical significance are as follows: *P 5 .01 to .05; **P # .01. Note: The electron density of the a-granule matrix at
0 seconds appeared similar for platelets from WT and all 3 SNARE variants.
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significant effect on a-granule secretion. These results biochemically
validate the strains used here.33
At the ultrastructural level, the V2D3D82/2 platelets appeared to
produce slightly smaller a-granules (compare Figure 1A and
Figure 2C, resting platelets). To address this quantitatively, we
scoreda-granule size and number in platelet thin sections. As shown
in supplemental Figure 2, a-granules in the V2D3D82/2 platelets
were ;70% the size of granules in wild-type (WT) platelets.
Quantitation revealed that a-granule size was not significantly
reduced in V82/2 or V2D3D platelets. a-Granule number, ;5.4
profiles per platelet section, varied by small but insignificant amounts
across the SNARE variants. Overall, these results suggest that
VAMP2/3/8 contribute to a-granule biogenesis. The incidence of
dense granules, 0.6 per resting platelet profile in thin section, was
unaffected by VAMP variation.
a-Granule decondensation is SNARE dependent
As predicted, thin section electron microscopy experiments
established a precursor-product relationship between condensed
and decondensed a-granules. By thin section, isolated, washed
mouse platelets (0 seconds) were relatively discoid in shape and
contained a-granules of 150 to 200 nm in diameter with an electron
dense matrix (Figure 1A, arrow). Upon stimulation with thrombin, the
platelets became rounded and extended pseudopods (Figure 1B-C).
With respect to a-granule structure (Figure 1B, 90 seconds
stimulation, white arrowheads), granules were frequently decon-
densed and had a ;23 greater diameter. Within the interior of a
decondensed a-granule, the matrix appeared fibrous with a lower
electron density, suggesting cargo release. The frequency
of condensed a-granules decreased with time, from an average of
;5 per platelet profile to ,1, over 300 seconds. The frequency of
0 sec
90 sec
300 sec
A B C
D E F
G H I
1 m 1 m
1 m 1 m
1 m
1 m
1 m
Figure 3. Condensed and decondensed a-granules distribution remains predominantly central during shape change in stimulated platelets. Each row shows
various views of the same platelet. (A,D,G) Individual slices from SBF-SEM image stacks showing changes in platelets at various times of stimulation. Blue arrows indicate
condensed granules; tan/yellow arrows indicate decondensed granules. (B,E,H) Condensed granules are rendered in blue, and decondensed granules in tan/yellow. (C,F,I)
PM is rendered in green. A decondensed granule appeared to be connected to the PM via a long pipe as shown in panel F. Supplemental Figure 3 Movie shows the
90 seconds rendered example rotated in 3-dimensional space. a-Granule surface area and sizes were quantified from similar renderings for multiple randomly chosen
platelets (see Figure 4 for additional examples), and the quantitation of their characteristics is reported in Tables 1 and 2.
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decondensed a-granules correspondingly increased for the first 90
seconds of stimulation. At 90 seconds stimulation, the average numbers
for condensed and decondensed a-granules together equaled ;5,
consistent with the values at 0 seconds. At later time points, the sum
of granules was less, as the frequency of condensed granules
decreased while that of decondensed granules failed to increase and,
in fact, decreased slightly. We attribute this decrease to compound,
granule-granule fusion, a process already apparent at 90 seconds
(Figure 1B, arrowheads). Significantly, even at 300 seconds stimulation,
decondensed a-granules retained fibrous content (Figure 1C). This
retention of fibrous a-granule matrix components following granule
decondensation was consistent with the relatively low extent of protein
secretion (eg, PF4 release; supplemental Figure 1). In comparison,
release of adenosine diphosphate, a small molecule, from dense
granules was nearly 80%.
We next tested the effects of deleting the v-SNARE, VAMP8, on
thrombin-stimulated, a-granule decondensation. VAMP8 is consid-
ered the primary v-SNARE involved in a-granule secretion.23 We
found platelets from V82/2 mice exhibited a kinetic delay in
a-granule matrix decondensation. Following 90 seconds stimula-
tion, few decondensed a-granules were apparent in V82/2
platelets, whereas after 300 seconds stimulation, decondensed
granules were abundant and compound granule fusion was evident
(Figure 2). As expected, V2D3D platelets behaved like WT
(Figure 2B). However, and consistent with the biochemical data
(supplemental Figure 1), loss of VAMP8 on a V2D3D background,
strongly inhibited a-granule decondensation after both 90 and 300
seconds of thrombin stimulation. As quantified in Figure 2D-E, these
data strongly indicate that a-granule decondensation is SNARE-
dependent and, moreover, that matrix decondensation/cargo
expulsion is likely dependent on fluid (ie, water) influx from the
blood plasma.
a-Granule decondensation results in a stepwise
transition in granule size
Figures1and 2 indicate that SNARE-dependent fusion of a-granules,
presumably to PM and/or CS, is the route for the water influx
resulting in granule decondensation. If, instead, regulated water
channels (eg, aquaporins) were the source of water influx, then one
might expect a-granules to swell gradually upon platelet activation
and/or prior to membrane fusion. Alternatively, if actin-dependent
granule constriction were the driving force for matrix expulsion, then
it should be detectible. To test these predictions, we assessed
a-granule volumes in unstimulated platelets (t 5 0 seconds) and in
platelets after stimulation, using SBF-SEM. With this approach,
imaging to a depth of ;7.5 mm provides a sufficient volume to
contain whole platelets in several orientations. As illustrated in
Figures 3 and 4, condensed a-granules (blue) in platelets, following
90 seconds stimulation, exhibited little to no change in volume
relative to unstimulated platelets. Comparison of the mean surface
area and volume showed no significant size difference between
condensed a-granules in unstimulated platelets and in platelets
after 90 seconds of stimulation. Moreover, decondensed
a-granules (tan) at 90 and 300 seconds stimulation showed similar
enlargement as a-granules located more centrally in platelets
at 300 seconds stimulation (Figure 3; Table 1). Decondensed
granules remained enlarged during the entire 300 seconds stimulus
period indicative of a stable, abrupt change in granule condensation
(Table 1). Importantly, the total a-granule surface area per platelet
remained constant (Table 2) indicating that there was no detectable
collapse of the granule membrane into the PM/CS. Together, these
observations strongly indicate a stepwise, fusion-dependent,
irreversible transition between 2 granule states that are character-
ized morphologically by differences in size and matrix density. In
our ex vivo thin section experiments, where fixative was added to
suspended platelets at time intervals of 10 or 20 seconds (Figure 1),
A B C D E
1000 nm
Figure 4. Peripheral a-granules appear to decondense first upon stimulation. Renderings from SBF-SEM of 5 different platelets, stimulated for 90 seconds (A-E) are
shown. Condensed granules are rendered in blue, decondensed granules are rendered in tan/yellow, and PM is rendered in green. Arrows point to examples of peripherally
located, decondensed granules. Quantification of granule sizes is tabulated in Table 1. Bar represents 1 mm.
Table 1. Individual a-granule surface area and volume increased
upon thrombin stimulation
Time, s
a-Granules
Surface area per
granule, mm2
Volume per
granule, mm3
Condensed Decondensed Condensed Decondensed
0 0.37 6 0.017 ND 0.017 6 0.001 ND
N 5 125 N 5 125
90 0.44 6 0.027 0.85 6 0.26 0.019 6 0.001 0.056 6 0.023
N 5 69 N 5 19 N 5 69 N 5 19
P 5 .02 P 5 .19
300 ND 0.88 6 0.16 ND 0.055 6 0.012
N 5 51 N 5 51
P 5 .05 P 5 .002
WT mouse platelets were stimulated with thrombin for the indicated times. a-Granule
surface area and volumes per platelet were determined from full platelet depth images
derived from SBF-SEM image stacks. Five platelets were rendered and quantified at each
time point (N 5 total number of condensed or decondensed granules scored at each time
point). Bolded numbers were used for P value comparisons. For surface area, significant
P values (calculated with Student t test) were seen for 2 comparisons: condensed at 0 vs
90 s (P 5 .02) and condensed at 90 s vs decondensed at 300 s (P 5 .05). Volume
comparisons showed significant P values for only the condensed at 90 s vs decondensed
at 300 s comparison (P 5 .002).
ND, not detected.
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we failed to detect any accumulation of intermediates suggesting that
the transition occurred on a time scale of no more than seconds. Based
on the detection of exocytosis intermediates (at 90 and 300 seconds)
and granule swelling reported in Table 2, our experimental design
appears insensitive to any delay in fixation kinetics.25 This is
consistent with other reports, from cultured, hippocampal neurons,
indicating that chemical fixation is sufficiently rapid (#1 second) to
stop secretory processes.38
a-Granule decondensation occurs first in
peripheral a-granules
As observed in stimulated platelets (90 seconds), decondensed
granules (tan) were predominantly located at the cell periphery,
whereas condensed granules (blue) were typically more central
(Figures 3 and 4; supplemental Figure 3 Movie). In several platelets,
the decondensed a-granules appeared almost adjacent/connected
to the PM. This pattern was seen in most activated platelets,
especially at early time points; however, because of the shape
changes occurring during platelet activation, it is difficult to
quantitatively measure the spatial distributions of the 2 granule
populations. Such detailed image analysis is beyond the scope of
the present work.
a-Granule fusion with the PM/CS or a decondensed
a-granule induces matrix decondensation,
progressing from the site of membrane fusion
Wehave shown previously, by ET, that the Z-resolution of 3-dimensional
imaging methods must be sufficient to detect granule fusion pores,
which in mouse platelets can be$30 nm diameter.33 To achieve higher
Z-resolution, we used FIB-SEM, which provides a nominal isotropic X,
Y, Z pixel size of ;5 nm. With the FIB-SEM, we expected to capture
3-dimensional volumes containing granule fusion events, albeit rare, in
which the processes of matrix decondensationwere inmidstage. If such
processes were because of solvent (ie, water) influx at the fusion zone,
then matrix decondensation would propagate from the fusion site. This
is illustrated with 2 examples: one in which the CS fuses with a
condensed granule (Figure 5A-F), and the other in which there is
granule-to-granule fusion (Figure 5G-L). At 90 seconds stimulation,
granule matrix decondensation propagates directly from the granule-CS
fusion site (Figure 5A-F, arrows). A similar behavior was seen for
compound granule fusion (Figure 5G-L, arrows). In Figure 5L, the set of
fusing/fused a-granules are rendered in 3-dimensional space and
displayed at a slight tilt to a plane perpendicular to the FIB-SEM images.
We conclude that the fusion pore, produced either by coupling the
granule through a neck or a pipe or by the larger granule-to-granule
fusion zone, is the entry point for the water influx required for
a-granule matrix hydration and subsequent cargo release.
Decondensed a-granules track back to fusion pores
occurring with either the PM or CS for single fusion or
other granules for compound fusion
Using FIB-SEM, we scored the frequency at which decondensed
a-granules tracked to fusion pores connected either to the PM, to
the CS, or, via compound granule-granule fusion, to the PM/CS, in
10 whole platelets, at 90 and 300 seconds of stimulation. We
expected a high incidence of fusion-pore-anchored, decondensed
granules, whose frequency would be ,100% for 2 reasons:
(1) fusion pore formation can be unstable33, and (2) fusion pore
detection is resolution-dependent. Even at 5-nm Z-resolution, the
angle of presentation and the width of the pore can make them
difficult to distinguish. Stimulated platelets displayed multiple
classes of granules anchored to membrane fusion pores. These
included single a-granules fused to the PM, compound fused
a-granules anchored to a PM fusion pore, and compound fused
granules anchored to a CS fusion pore. Representative examples of
pore anchored and unanchored decondensed granule classes are
shown in Figure 6. Quantitatively, fusion-pore-anchored granules
were linked fourfold more frequently to the PM than CS (Table 3).
Considering that a “string” of compound fused a-granules could
consist of 2 to 5 granules linked together, the number of compound
fusion events likely exceeds the number of primary fusion events to
PM/CS. Electron tomography of 300-nm-thick sections (Z-step size
1.5 nm) gave a ratio of ;4 with a strong dependence of both
primary and compound fusion on SNARE expression with V82/2
platelets exhibiting a transitory inhibition at 90 seconds stimulation
and the V2D3D82/2 platelets exhibiting a near complete fusion
block (supplemental Figure 4). These results are consistent with the
earlier thin section quantification of granule frequency in stimulated
V2D3D82/2 platelets (Figure 2). In these platelets, no examples of
compound fusion were detected even after 300 seconds stimula-
tion, whereas compound fusion was abundant in stimulated
platelets from V2D3D or V82/2 mice at the same time point.
In sum, a-granule decondensation is predominantly anchored to
SNARE-dependent fusion pores, either to PM, the dominant event,
or to the CS. We conclude that a-granule cargo expulsion is linked
directly, in the case of primary fusion to PM/CS, and indirectly, in the
case of compound granule fusion. In all cases, VAMP-dependent
matrix hydration is necessary to initiate cargo expulsion.
Table 2. Total a-granule surface area and volume per platelet showed little to no change upon thrombin stimulation
Time, s
Surface area per platelet, mm2 Volume per platelet, mm3 Total
Condensed Decondensed Condensed Decondensed Area, mm2 Volume, mm3
0 9.34 6 4.15 ND 0.43 6 0.18 ND 9.34 0.43
90 6.07 6 3.12 3.29 6 3.26 0.26 6 0.10 0.21 6 0.24 9.36 0.47
P 5 .22 P 5 .13
300 ND 9.00 6 3.20 ND 0.56 6 0.24 9.00 0.56
P 5 .02* P 5 .03*
WT mouse platelets were stimulated with 0.1 U/mL thrombin for the indicated times. Total a-granule surface area and volume per platelet were determined from full platelet depth
SBF-SEM image stacks. Five platelets were rendered and quantified at each time point. Asterisks indicate statistically significant comparisons within the table columns, as calculated with
Student t test. *P 5 .01 to .05.
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Discussion
We addressed here a central aspect of the platelet release reaction,
namely, what is driving the expulsion of a-granule matrix proteins.
Based on analogies to previous work with platelets1-3 and the closely
related WPBs of endothelial cells,9 we considered 3 possible
mechanisms: (1) a jack-in-the-box mechanism driven by SNARE-
dependent water influx and subsequent protein phase transitions9,24,25;
(2) a regulated channel-dependent water influx with granule
swelling prior to fusion (analogous to the membrane ballooning
in procoagulant platelets)28; and (3) an actin-driven granule
constriction.26,27 We reasoned that determining the kinetics and
molecular requirements for the conversion of thea-granulematrix from a
condensed to a decondensed state would provide a key readout of
granule matrix hydration, which we posit is an underlying prerequisite for
cargo expulsion. Experimentally, we used thrombin stimulation for varied
durations to test the kinetics of the process and used isolated mouse
platelets from WT and SNARE-deficient mice to test the molecular
requirements. Our readout for granule size/shape and matrix
A B C
D E F
G H I
J K L
500 nm
500 nm
Figure 5. a-Granule matrix decondensation propagates
from open canalicular system–granule fusion or
decondensed-condensed granule fusion sites. Images
are individual slices from FIB-SEM image stacks, and the frames
shown are spaced 15 nm apart. (A-F) The blue arrow indicates
a condensed a-granule, and the yellow indicates open canalic-
ular system–elements (A). The variegated blue/yellow arrow-
head indicates a CS-granule fusion zone (B). The dark tubular
structures adhering to the decondensing a-granule are ele-
ments of dense tubular network. (G-L) The tan arrow indicates
a decondensed a-granule (G), and the blue arrow indicates a
condensed a-granule (G). The variegated tan/blue arrowhead
indicates the decondensed-condensed granule fusion zone in
the FIB-SEM slice (I) and similarly marks the fusion zone in a
rendering (L) that is slightly tilted from the perpendicular relative
to the FIB-SEM image planes. Bars represent 0.5 mm.
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decondensation was direct observation by electron microscopy, be
it thin section, SBF-SEM, FIB-SEM, or ET. Based on testing multiple
experimental predictions, we conclude that platelet a-granule cargo
expulsion uses a jack-in-the-box mechanism in which water influx
and cargo expulsion are initiated by SNARE-dependent membrane
fusion and subsequent granule matrix decondensation (Figure 7).
SNARE dependence was exhibited at multiple stages, during
primary granule fusion predominantly with the PM and secondarily
with the CS and during sequential compound fusion of granules to a
fusion pore anchored a-granule. Importantly, our results position the
hydration kinetics of the a-granule matrix as a significant determining
factor in the time-dependent release of a-granule contents.18
We used SNARE dependence as a tool to probe the decondensation
process.33 Based on previous experimentation, we expected the
v-SNARE, VAMP8,23,33,39 would be important but not required for
a-granule decondensation and granule matrix solubilization.
This indeed proved to be the case. VAMP8 deletion alone produced
a transient delay in a-granule decondensation presumably because
of the ability of VAMP734 to partially compensate. The V2D3D82/2
platelets showed a near complete block in a-granule matrix
decondensation, consistent with their secretion defects.33We attribute
this to VAMP237 and VAMP337 being involved in endocytic
trafficking that reduces VAMP7 levels, indirectly. The importance
of the coordination between VAMP7 and 8 levels and how
A B
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E F
G H
200 nm
200 nm
200 nm
200 nm 200 nm
200 nm
200 nm
200 nm
90 sec
300 sec
Figure 6. Decondensed a-granule membrane fusion in
thrombin-stimulated platelets. Platelets were imaged by
FIB-SEM at a nominal resolution of 5 nm in XYZ. Tan arrows
point to examples of membrane fusion; 90 seconds stimulation
(A-F) and 300 seconds stimulation (G-H). The left column shows
single-slice images of platelets, and the right shows rendered
images of decondensed granules (tan) and the PM (green). Two
image sets show granules that track to the PM at 90 seconds
stimulation, in one (A-B), the granule is linked to the PM fusion
pore via a short neck, while in the other case the linkage to the
fusion pore is by a longer pipe (C-D). (E-F) Two granules fused
laterally (compound fusion), and these fail to track to either a PM
or CS fusion pore complex. (G-H) A PM-granule fusion at
300 seconds with a larger neck/pipe. The blue arrow in panel G
points to a rare condensed a-granule seen in a 300 seconds
stimulated platelet. The incidence of a-granule fusion with PM
and CS at various time points is quantified in Table 3. Bars
represent 0.2 mm.
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VAMP2/3 affects this are still open questions. However, a key
conclusion remains that the reduced levels of VAMP7 cannot
completely compensate for the loss of VAMP8 in the V2D3D
background. This evidence reaffirms the previous conclusion of
Ren et al23 that VAMP8 is the primary v-SNARE involved in
a-granule secretion. Moreover, the present work extends the
studies of Ren et al23 and Eckly et al19 to indicate that a-granule
matrix decondensation is SNARE dependent. Matrix decondensation
required SNARE-mediated membrane fusion to the PM, CS, or a
decondensing a-granule. This dependence can be readily explained
by fusion-pore-dependent water influx but not by channel-regulated
water influx and prefusion granule swelling. Moreover, our obser-
vations that granule matrix decondensation radiated from the site
of membrane fusion provide striking validation of fusion-pore-
dependent water influx. In brief, we conclude that the fusion pore is
the site of water entry. The reader should note that we are using the
term “water” in a generic sense. The fusion pore is open to an influx of
extraplatelet fluid, be it plasma or buffer, which is needed to rehydrate
and solubilize the concentrated granule contents.
Overall, these results strongly suggest that primary and compound
a-granule membrane fusion are coupled processes. Any inhibition of
primary fusion to the PM correlated with an inhibition of compound
fusion. As to which membranes are involved, PM or CS, in previous
experiments with human platelets, we failed to observe any
a-granule fusion with CS, conceivably a consequence of the small
sample size.6 However, Eckly et al19 did report isolated examples
of granule/CS fusion in mouse platelets. In our present study of
mouse platelets, we observed a predominance (;80%) of primary
a-granule fusion with PM. From our data, ;75% of granule
decondensation, be it of single or compound fused granules,
tracked back to a membrane fusion pore. The remaining 25% of
decondensed granules exhibited no detectable fusion-pore anchoring.
We attribute this to 2 limiting factors: a technical limit, the
nominal 5-nm Z-step size achieved in the FIB-SEM imaging and a
biological factor, the possible dynamic instability of the fusion
pore. As cited previously, the near absolute dependence of
granule decondensation on v-SNAREs provides an additional
compelling argument that pore detection in one form or another may
be the limiting factor. In Figure 7, we propose a model in which
compound a-granule fusion is the sequential outcome of primary
a-granule fusion to PM or CS followed by a redistribution of t-SNAREs
to support successive rounds of granule-granule fusion. Such a
t-SNARE distribution has been reported for SNAP-23 in mast cells.40
Similar models have been proposed to support a jack-in-the-box
mechanism of VWF release from compound fusedWPBs in endothelial
cells.9,24,25 We found no ultrastructural evidence in mouse platelets
for granule constriction and hence suggest that the alternative actin-
dependent WPB constriction model proposed in endothelial cells
does not apply to thrombin-stimulated platelets. Consistent with this
suggestion, actin disruptors such as latrunculin have been shown to
have varied effects on the a-granule release reaction.29-32
Water molecules
SNAP23
Syntaxin-11
VAMP8/7
Compound Fusion
Primary Fusion
Granule Decondensation
Cargo Release
PM/CS
(80:20)
–Granule
Figure 7. Graphic summary of the role of a-granule decon-
densation in granule cargo release. In this illustration, we
represent the observed steps that occur during decondensation
and release of a-granule contents. The v- and t-SNAREs
(ie, VAMP8/7 and syntaxin-11/SNAP23) are indicated. SNARE-
mediated fusion, water influx (blue circles), and granule/matrix
decondensation are depicted as a sequence of events. Both primary
and compound granule-granule fusion are shown.
Table 3. Site of a-granule fusion pore anchoring following thrombin
stimulation
Thrombin stimulation
90 s,
0.1 U/mL
300 s,
0.1 U/mL
PM anchored
Single decondensed a-granule 31% 35%
N 5 21 N 5 32
Compound fused decondensed a-granule string 30% 29%
N 5 20 N 5 26
CS anchored
Single decondensed a-granule anchored to CS pore 15% 11%
N 5 10 N 5 10
Unanchored
Single decondensed a-granule 1% 12%
N 5 1 N 5 11
Compound fused decondensed a-granule string 22% 13%
N 5 14 N 5 12
Relative frequency Total events 66 Total events 89
PM anchored 61% 64%
CS anchored 15% 11%
Unanchored 23% 25%
WT mouse platelets were stimulated with 0.1 U/mL thrombin for the indicated times.
a-Granule fusion events were determined for all a-granules found in 10 randomly chosen
platelets presenting in full platelet depth FIB-SEM image stacks at each time point.
Granules were tracked at a nominal 5-nm Z-step resolution from image slices to score, in
3-dimensional space, whether the granule was anchored to a PM or CS pore complex.
Image pixel size in XY was 5 nm 3 5 nm.
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In conclusion, we propose that the structural and functional
consequences of granule matrix organization are underappreciated
contributory factors to platelet function. A structured matrix could
confer timed-release properties to a-granule cargo based on
differential matrix dissociation kinetics. Evidence for sequential
a-granule cargo release has been presented in the literature.18
Timed cargo release could be physiologically important to thrombus
formation or its sequela (eg, wound healing and angiogenesis).
Furthermore, cargo interactions within the a-granule matrix may be
important for stabilizing protein accumulation within the granule.
These interactions may well be dependent, at the molecular level, on
factors such as pH, [Ca21], and membrane potential, all of which
are conceivable drug targets.
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